Applying Inhaled Furosemide for Refractory Breathlessness in Terminally-ill Cancer Patients - Based on Seminar of Palliative Medicine Research Group, The Korean Academy of Family Medicine -
![]() |
Hwang, In-Cheol
(Department of Family Medicine, Gachon University Gil Hospital)
Lee, Min-Kyu (Department of Family Medicine, Gachon University Gil Hospital) Kim, Kyoung-Kon (Department of Family Medicine, Gachon University Gil Hospital) Lee, Kyoung-Sik (Department of Family Medicine, Gachon University Gil Hospital) Suh, Heuy-Sun (Department of Family Medicine, Gachon University Gil Hospital) |
1 | Kohara H, Ueoka H, Aoe K, Maeda T, Takeyama H, Saito R, et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J Pain Symptom Manage 2003;26(4):962-7. DOI ScienceOn |
2 | Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 2008;26(14):2396-404. DOI ScienceOn |
3 | Thomas JR, von Gunten CF. Clinical management of dyspnoea. Lancet Oncol 2002;3(4):223-8. DOI ScienceOn |
4 | Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med 2007;21(3):177-91. DOI ScienceOn |
5 | Newton PJ, Davidson PM, Macdonald P, Ollerton R, Krum H. Nebulized furosemide for the management of dyspnea: does the evidence support its use? J Pain Symptom Manage 2008;36(4):424-41. DOI ScienceOn |
6 | Wilcock A, Walton A, Manderson C, Feathers L, El Khoury B, Lewis M, et al. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer. Thorax 2008;63(10):872-5. DOI ScienceOn |
7 | Mercadante S, Casuccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000;20(2):104-12. DOI ScienceOn |
8 | Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986;89(2):234-6. DOI ScienceOn |
9 | Cachia E, Ahmedzai SH. Breathlessness in cancer patients. Eur J Cancer 2008;44(8):1116-23. DOI ScienceOn |
10 | Gwak JI, Suh SY. The assessment tools in palliative medicine. Korean J Hosp Palliat Care 2009;12(4):177-93. 과학기술학회마을 |
11 | American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999;159(1):321-40. DOI ScienceOn |
12 | Stone P, Kurowska A, Tookman A. Nebulized frusemide for dyspnoea. Palliat Med 1994;8(3):258. DOI ScienceOn |
13 | Bianco S, Vaghi A, Robuschi M, Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet 1988;2(8605):252-5. |
![]() |